Coagadex Approved for Rare Clotting Disorder

WEDNESDAY, Oct. 21, 2015 — Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X…
Source: Topamax